Literature DB >> 21493895

Activation of endothelial toll-like receptor 3 impairs endothelial function.

Sebastian Zimmer1, Martin Steinmetz, Tobias Asdonk, Inga Motz, Christoph Coch, Evelyn Hartmann, Winfried Barchet, Sven Wassmann, Gunther Hartmann, Georg Nickenig.   

Abstract

RATIONALE: Endothelial dysfunction and atherosclerosis are chronic inflammatory diseases characterized by activation of the innate and acquired immune system. Specialized protein receptors of the innate immune system recognize products of microorganisms and endogenous ligands such as nucleic acids. Toll-like receptor 3 (TLR3), for example, detects long double-stranded RNA and is abundantly expressed in endothelial cells. Whether innate immunity contributes to atherogenic mechanisms in endothelial cells is poorly understood.
OBJECTIVE: We sought to determine the effects of TLR3 activation in endothelial cells. METHODS AND
RESULTS: We first investigated whether stimulation of TLR3 influences endothelial biology in mice. Intravenous injection of polyinosine polycytidylic acid, a synthetic double-stranded RNA analog and TLR3 ligand, impaired endothelium-dependent vasodilation, increased vascular production of reactive oxygen species, and reduced reendothelialization after carotid artery injury in wild-type mice compared with controls but had no effect in TLR3(-/-) animals. TLR3 stimulation not only induced endothelial dysfunction but also enhanced the formation of atherosclerotic plaques in apolipoprotein E-deficient mice. In vitro incubation of endothelial cells with polyinosine polycytidylic acid induced production of the proinflammatory cytokines interleukin-8 and interferon-γ-induced protein 10, increased formation of reactive oxygen species, diminished proliferation, and increased apoptosis, which suggests that endothelial cells are able to directly detect and respond to TLR3 ligands. Neutralization of interleukin-8 and interferon-γ-induced protein 10 antagonizes the observed negative effects of polyinosine polycytidylic acid. We found elevated levels of circulating endothelial progenitor cells in polyinosine polycytidylic acid-treated mice, although they displayed increased endothelial dysfunction. Stimulation of TLR3 in cultured endothelial progenitor cells, however, led to increased formation of reactive oxygen species, increased apoptosis, and reduced migration. Injection of endothelial progenitor cells that had been incubated with polyinosine polycytidylic acid ex vivo hindered reendothelialization after carotid artery injury. Therefore, endothelial progenitor cell function was affected by TLR3 stimulation. Finally, apolipoprotein E-deficient/TLR3-deficient mice exhibited improved endothelial function compared with apolipoprotein E-deficient/TLR3(+/+) littermates.
CONCLUSIONS: Immunorecognition of long double-stranded RNA by endothelial cells may be an important mechanism involved in endothelial cell activation and development of endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493895     DOI: 10.1161/CIRCRESAHA.111.243246

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  44 in total

1.  Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension.

Authors:  Daniela Farkas; A A Roger Thompson; Aneel R Bhagwani; Schuyler Hultman; Hyun Ji; Naveen Kotha; Grant Farr; Nadine D Arnold; Adam Braithwaite; Helen Casbolt; Jennifer E Cole; Ian Sabroe; Claudia Monaco; Carlyne D Cool; Elena A Goncharova; Allan Lawrie; Laszlo Farkas
Journal:  Am J Respir Crit Care Med       Date:  2019-01-15       Impact factor: 21.405

2.  An LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux.

Authors:  Mark A Gillespie; Elizabeth S Gold; Stephen A Ramsey; Irina Podolsky; Alan Aderem; Jeffrey A Ranish
Journal:  EMBO J       Date:  2015-03-09       Impact factor: 11.598

Review 3.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

4.  The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.

Authors:  Lukasz Stawski; Grace Marden; Maria Trojanowska
Journal:  J Immunol       Date:  2017-11-15       Impact factor: 5.422

5.  Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.

Authors:  Sebastian Zimmer; Alena Grebe; Siril S Bakke; Niklas Bode; Bente Halvorsen; Thomas Ulas; Mona Skjelland; Dominic De Nardo; Larisa I Labzin; Anja Kerksiek; Chris Hempel; Michael T Heneka; Victoria Hawxhurst; Michael L Fitzgerald; Jonel Trebicka; Ingemar Björkhem; Jan-Åke Gustafsson; Marit Westerterp; Alan R Tall; Samuel D Wright; Terje Espevik; Joachim L Schultze; Georg Nickenig; Dieter Lütjohann; Eicke Latz
Journal:  Sci Transl Med       Date:  2016-04-06       Impact factor: 17.956

Review 6.  Nucleic Acid Delivery for Endothelial Dysfunction in Cardiovascular Diseases.

Authors:  Dipti Deshpande; David R Janero; Victor Segura-Ibarra; Elvin Blanco; Mansoor M Amiji
Journal:  Methodist Debakey Cardiovasc J       Date:  2016-09

7.  Toll-Like Receptor-3 Mediates HIV-1-Induced Interleukin-6 Expression in the Human Brain Endothelium via TAK1 and JNK Pathways: Implications for Viral Neuropathogenesis.

Authors:  Biju Bhargavan; Georgette D Kanmogne
Journal:  Mol Neurobiol       Date:  2017-11-11       Impact factor: 5.590

Review 8.  Targeting pattern recognition receptors in cancer immunotherapy.

Authors:  Nadège Goutagny; Yann Estornes; Uzma Hasan; Serge Lebecque; Christophe Caux
Journal:  Target Oncol       Date:  2012-03-08       Impact factor: 4.493

Review 9.  The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease.

Authors:  Ying Zhou; Peter J Little; Liam Downey; Rizwana Afroz; Yuao Wu; Hang T Ta; Suowen Xu; Danielle Kamato
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-06

10.  Bone marrow-derived Kruppel-like factor 10 controls reendothelialization in response to arterial injury.

Authors:  Akm Khyrul Wara; Andre Manica; Julio F Marchini; Xinghui Sun; Basak Icli; Yevgenia Tesmenitsky; Kevin Croce; Mark W Feinberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-16       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.